Insys Therapeutics, Inc. Current Assets
Insys Therapeutics, Inc. had Current Assets of $105.73 million as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2019-05-13
- 2019-03-31: Assets, Current $105.73M.
- 2018-12-31: Assets, Current $126.29M.
- 2018-09-30: Assets, Current $145.48M.
- 2018-06-30: Assets, Current $156.11M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2019-03-31 | $105.73M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $126.29M 10-Q · filed 2019-05-13 | |
| 2018-09-30 | $145.48M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $156.11M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $166.69M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $175.94M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $179.86M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $197.19M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $196.94M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $229.64M 10-K · filed 2018-03-12 | $230.97M 10-K · filed 2017-04-03 |
| 2016-09-30 | $235.83M 10-Q/A · filed 2017-04-07 | $235.23M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $233.04M 10-Q/A · filed 2017-04-07 | $233.99M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $220.61M 10-Q/A · filed 2017-04-07 | $220.75M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $252.05M 10-Q/A · filed 2017-04-07 | $253.24M 10-K · filed 2016-02-29 |
| 2015-09-30 | $231.12M 10-Q/A · filed 2017-04-07 | $236.63M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $191.81M 10-Q/A · filed 2017-04-07 | $198.24M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $174.29M 10-Q/A · filed 2017-04-07 | $182.09M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $146.43M 10-K · filed 2016-02-29 | $151.04M 10-K · filed 2015-03-03 |
| 2014-09-30 | $128.69M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $102.21M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $91.31M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $82.15M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $57.73M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $40.58M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $15.73M 10-Q · filed 2013-06-05 | |
| 2012-12-31 | $11.89M 10-K · filed 2014-03-05 |